Stratasys Ltd. (NASDAQ:SSYS) Receives Consensus Rating of “Moderate Buy” from Brokerages

Shares of Stratasys Ltd. (NASDAQ:SSYS) have received a consensus recommendation of “Moderate Buy” from the five analysts that are currently covering the stock, MarketBeat.com reports. One equities research analyst has rated the stock with a hold rating and four have assigned a buy rating to the company. The average 1-year price target among brokers that have updated their coverage on the stock in the last year is $10.80.

SSYS has been the subject of a number of research reports. Lake Street Capital lowered their price target on Stratasys from $15.00 to $11.00 and set a “buy” rating for the company in a report on Friday, August 30th. StockNews.com assumed coverage on Stratasys in a research note on Monday, September 2nd. They set a “hold” rating on the stock. Loop Capital lowered their price objective on shares of Stratasys from $9.00 to $7.00 and set a “hold” rating for the company in a research note on Thursday, September 5th. Needham & Company LLC dropped their target price on shares of Stratasys from $12.00 to $10.00 and set a “buy” rating on the stock in a report on Friday, August 30th. Finally, Cantor Fitzgerald reduced their price target on shares of Stratasys from $23.00 to $12.00 and set an “overweight” rating for the company in a report on Friday, August 30th.

Stratasys Trading Up 0.1 %

Shares of NASDAQ:SSYS opened at $7.15 on Friday. The company has a 50-day moving average price of $7.34 and a 200 day moving average price of $8.32. Stratasys has a 12 month low of $6.05 and a 12 month high of $14.93. The company has a market cap of $510.35 million, a price-to-earnings ratio of -4.39 and a beta of 1.19.

Stratasys (NASDAQ:SSYS) last released its earnings results on Thursday, August 29th. The technology company reported ($0.04) earnings per share for the quarter, topping the consensus estimate of ($0.05) by $0.01. The business had revenue of $138.00 million during the quarter, compared to the consensus estimate of $146.38 million. Stratasys had a negative return on equity of 3.29% and a negative net margin of 18.98%. The business’s revenue for the quarter was down 13.6% compared to the same quarter last year. During the same period last year, the company earned ($0.08) earnings per share. As a group, equities analysts forecast that Stratasys will post -0.44 EPS for the current year.

Hedge Funds Weigh In On Stratasys

Several institutional investors and hedge funds have recently added to or reduced their stakes in SSYS. Crewe Advisors LLC bought a new stake in shares of Stratasys in the 1st quarter valued at about $61,000. Larson Financial Group LLC boosted its stake in Stratasys by 2,711.2% in the first quarter. Larson Financial Group LLC now owns 9,558 shares of the technology company’s stock valued at $111,000 after acquiring an additional 9,218 shares in the last quarter. Values First Advisors Inc. grew its holdings in Stratasys by 51.3% in the second quarter. Values First Advisors Inc. now owns 33,175 shares of the technology company’s stock worth $278,000 after purchasing an additional 11,254 shares during the last quarter. Gamco Investors INC. ET AL increased its position in shares of Stratasys by 4.0% during the first quarter. Gamco Investors INC. ET AL now owns 48,659 shares of the technology company’s stock worth $565,000 after purchasing an additional 1,850 shares in the last quarter. Finally, Tidal Investments LLC purchased a new stake in shares of Stratasys during the 1st quarter valued at $598,000. Hedge funds and other institutional investors own 75.77% of the company’s stock.

About Stratasys

Stratasys Ltd. provides connected polymer-based 3D printing solutions. It offers range of 3D printing systems, which includes polyjet printer, Fused Deposition Modeling (FDM) printers, stereolithography printing systems, origin P3 printers, and selective absorption fusion printer for additive manufacturing, and tooling and rapid prototyping for various vertical markets, such as automotive, aerospace, consumer products and healthcare.